Corcept Therapeutics Cash Flow from Investing Activities 2010-2025 | CORT
Corcept Therapeutics cash flow from investing activities for the twelve months ending March 31, 2025 was $-0.363B, a 207.12% decline year-over-year.
- Corcept Therapeutics annual cash flow from investing activities for 2024 was $-0.178B, a 295.37% decline from 2023.
- Corcept Therapeutics annual cash flow from investing activities for 2023 was $0.091B, a 179.51% decline from 2022.
- Corcept Therapeutics annual cash flow from investing activities for 2022 was $-0.114B, a 183.99% decline from 2021.